中国—中东国家新冠疫苗合作助力全球抗疫

Cooperation on COVID-19 Vaccine Between China and Middle East Countries Contributes to the Global Fight Against the Epidemic

面对迟迟未能结束的新冠疫情,全力加强防控和公共卫生治理成为全球抗疫的重要途径。中国作为最早爆发新冠疫情的国家,在政府主导和全民配合之下成功控制了疫情的蔓延,迅速进行疫苗研发,并与国际社会广泛开展合作。其中,中国与中东国家在疫苗研发、生产以及推广使用等领域的合作极其深入,塑造了国际疫苗合作的典范。双方联合抗疫助推了全球抗疫进度,深化了中国与中东国家关系,塑造了中国负责任的大国形象。

In the face of the continuing COVID-19,efforts on strengthening prevention and control and public health management have become an important way of global epidemic prevention.As the first country to experience the outbreak of the pandemic,China has successfully controlled the spread of the epidemic with the government’s leadership and the people’s cooperation throughout the country.China developed the vaccine rapidly and carried out extensive cooperation with the international community.The cooperation between China and Middle East countries in vaccine R&D,production,promotion and use is extremely profound which has offered a model of international vaccine cooperation.The joint antiepidemic efforts of the two sides have boosted the global fight against the epidemic,deepened the relations between China and Middle East countries,and shaped China’s image as a responsible major country.